Shares of Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) were down 1.3% during mid-day trading on Tuesday . The company traded as low as $38.06 and last traded at $39.72. Approximately 63,481 shares changed hands during trading, an increase of 49% from the average daily volume of 42,556 shares. The stock had previously closed at $40.23.
Wall Street Analyst Weigh In
Separately, UBS Group cut shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, February 3rd.
Read Our Latest Stock Report on SDZNY
Sandoz Group Trading Up 4.0 %
The company has a fifty day moving average price of $41.83 and a two-hundred day moving average price of $43.60.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
